Related Experiment Videos
Warfarin-griseofulvin interaction.
Drug Intelligence & Clinical Pharmacy
|April 1, 1986
Summary
Griseofulvin can significantly decrease the effectiveness of warfarin, requiring dose adjustments. Close monitoring of prothrombin time is essential when these medications are used together.
Area of Science:
- Pharmacology
- Drug Interactions
Background:
- Warfarin is a commonly prescribed anticoagulant for patients with mechanical heart valves.
- Therapeutic anticoagulation with warfarin requires careful monitoring of prothrombin time (PT).
Observation:
- A patient on long-term warfarin therapy experienced reduced anticoagulation after initiating griseofulvin.
- A 41% increase in warfarin dosage was necessary to maintain therapeutic levels.
- Decreasing griseofulvin dosage led to increased PT and a subsequent reduction in warfarin dose.
Findings:
- Griseofulvin significantly diminishes the therapeutic response to warfarin.
- This interaction necessitates careful dose titration of warfarin when co-administered with griseofulvin.
Implications:
- Clinicians should be aware of the potential for griseofulvin to reduce warfarin efficacy.
- Regular PT monitoring and warfarin dose adjustments are crucial for patients receiving both medications.
- Prompt recognition and management of this drug interaction can prevent thromboembolic events.